Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Intralesional Triamcinolone Acetonide With Intralesional Verapamil Hydrochloride in Keloids
NCT07420166Completed
- Start
- Jan 2025
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Trial of verapamil and triamcinolone acetonide in keloid (2 arms). Primary endpoint: Scar assessment at 24 weeks. Started Jan 2025; status: completed.
02
Drugs
verapamiltriamcinolone acetonide
03
Conditions
keloid
Beyond the preview
Go deeper on NCT07420166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07420166.